VoiceMed completes first financing round for respiratory monitoring
New public support and private investment bring the company’s total funding to €1 million.
VoiceMed has secured support from Invitalia and investments from GCM Group, Padda Health and 28Digital. The €1 million milestone represents total funding; the company did not give a separate amount for the newly completed round.
The financing supports clinical studies of smartphone-based respiratory monitoring for COPD and preparation for initial market entry. VoiceMed analyses voice and breathing recordings to research signals that could support monitoring outside hospital settings.
Use of funds
Accelerate clinical studies for home monitoring of COPD
Validate technology in real-world settings
Support initial market entry